Comparing of Varex Imaging Corporation (VREX) and Neovasc Inc. (NASDAQ:NVCN)

Varex Imaging Corporation (NASDAQ:VREX) and Neovasc Inc. (NASDAQ:NVCN), both competing one another are Medical Appliances & Equipment companies. We will contrast their risk, institutional ownership, analyst recommendations, profitability, dividends, earnings and valuation.

Earnings & Valuation

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
Varex Imaging Corporation 777.50M 1.44 12.70M 0.47 71.24
Neovasc Inc. 2.00M 16.06 60.78M -14.17 0.00

Table 1 demonstrates Varex Imaging Corporation and Neovasc Inc.’s top-line revenue, earnings per share (EPS) and valuation.

Profitability

Table 2 shows us Varex Imaging Corporation and Neovasc Inc.’s net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Varex Imaging Corporation 1.63% 4.5% 1.9%
Neovasc Inc. -3,039.00% 0% 0%

Analyst Ratings

The table given features the ratings and recommendations for Varex Imaging Corporation and Neovasc Inc.

Sell Ratings Hold Ratings Buy Ratings Rating Score
Varex Imaging Corporation 0 0 1 3.00
Neovasc Inc. 0 0 0 0.00

Varex Imaging Corporation has an average target price of $42, and a 44.03% upside potential.

Institutional and Insider Ownership

Varex Imaging Corporation and Neovasc Inc. has shares held by institutional investors as follows: 0% and 7.32%. Varex Imaging Corporation’s share held by insiders are 0.4%. Comparatively, 6.56% are Neovasc Inc.’s share held by insiders.

Performance

Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.

Performance (W) Performance (M) Performance (Q) Performance (HY) Performance (Y) Performance (YTD)
Varex Imaging Corporation 4.02% 17.02% 28.83% 5.07% -2.8% 40.79%
Neovasc Inc. -19.07% -30.21% -38.48% -85.67% -97.6% -15.42%

For the past year Varex Imaging Corporation had bullish trend while Neovasc Inc. had bearish trend.

Summary

Varex Imaging Corporation beats on 11 of the 12 factors Neovasc Inc.

Varex Imaging Corporation designs and manufactures medical X-ray tubes and image processing solutions. The company offers X-ray imaging components, such as tubes, digital flat panel detectors, and other image processing solutions, which are key components of X-ray imaging systems. Its components are used in medical imaging, as well as in industrial and security imaging applications. The company offers various medical imaging component products, including replacement X-ray tubes, OEM X-ray tubes, flat panel detectors, software solutions, Claymount high voltage connections, Claymount AEC sensors, Claymount collimators, and Claymount bucky systems, as well as components for cardiac, computed tomography (CT), dental, mammography, and radiography and fluoroscopy systems. Its imaging component products for security and industrial imaging needs include linear accelerators, industrial X-ray tubes, detectors, Attila software, industrial CT scanning services, and Claymount high voltage connections. The company has operations in North America, Europe, and Asia. Varex Imaging Corporation is headquartered in Salt Lake City, Utah.

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets cardiovascular devices worldwide. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company also provides Peripatch biological tissue products that are used as components in third-party medical products, such as transcatheter heart valves for industry partners and other customers. In addition, it offers consulting and original equipment manufacturing services to other medical device companies. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.